Broadfin Capital’s Accendra Health ACH Stock Holding History

Broadfin Capital’s Portfolio ACH Stock Details ACH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-133,700	Closed	-$3.9M	–	49
2017 Q3	$3.9M	Buy	+133,700	New	+$3.95M	0.58%	38

Other funds holding ACH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Broadfin Capital's ACH Position: Q4 2017 in Review

Broadfin Capital sold out of Accendra Health (ACH) in Q4 2017, closing a stake of 133,700 shares — an estimated $3.9M sold.

Broadfin Capital first reported a position in ACH in Q3 2017 and held it in 1 quarter. The position peaked at $3.9M in Q3 2017. 230 funds tracked by Wall St. Rank hold ACH as of Q4 2017.

Broadfin Capital reported no remaining Accendra Health position as of Q4 2017 after selling out during the quarter.
Broadfin Capital sold 133,700 Accendra Health shares in Q4 2017, an estimated $3.9M.
Broadfin Capital first reported a position in Accendra Health in Q3 2017 and held it in 1 quarter.
Broadfin Capital's Accendra Health position peaked at $3.9M in Q3 2017.
230 funds tracked by Wall St. Rank held Accendra Health as of Q4 2017.

Based on Broadfin Capital's 13F filing for Q4 2017, filed 13 Feb 2018.